Cargando…
Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: Real world evidence
INTRODUCTION: Dual antiplatelet treatment is recommended by current clinical practice guidelines for patients undergoing PCI. The PLATO trial showed superiority of ticagrelor to clopidogrel in reducing the rate of death from vascular causes, myocardial infarction and stroke without increase in the r...
Autores principales: | Kumar, Viveka, Kumar, Vivek, Kumari, Kajal, Talwar, K.K., Prasad, Divya, Agarwal, Sunil, Yadav, M.S., Bashir, Hamed, Jatain, Suman, Gupta, S.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Egyptian Society of Cardiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303273/ https://www.ncbi.nlm.nih.gov/pubmed/30591758 http://dx.doi.org/10.1016/j.ehj.2018.05.002 |
Ejemplares similares
-
Ticagrelor as an Alternative for Clopidogrel-Associated Acute Arthritis
por: Bedy, Starr-Mar'ee C., et al.
Publicado: (2018) -
Ticagrelor versus clopidogrel in the management of acute myocardial infarction
por: Volney, Candice, et al.
Publicado: (2019) -
Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
por: Peasah, Samuel K., et al.
Publicado: (2023) -
Hypersensitivity to ticagrelor and low response to clopidogrel: a case report
por: Dai, Jing, et al.
Publicado: (2017) -
Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of Treatment
por: Bergmeijer, Thomas O., et al.
Publicado: (2018)